Loading…

Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology

The clinical benefit of LDL cholesterol (LDL-C) lowering for cardiovascular disease prevention is well documented. This paper from the Italian Study Group on Atherosclerosis, Thrombosis and Vascular Biology summarizes current recommendations for treatment of hypercholesterolemia, barriers to lipid-l...

Full description

Saved in:
Bibliographic Details
Published in:Vascular pharmacology 2023-02, Vol.148, p.107137-107137, Article 107137
Main Authors: Patti, Giuseppe, Cavallari, Ilaria, Cesaro, Arturo, Gragnano, Felice, Riva, Letizia, Fimiani, Fabio, Cuccia, Claudio, Fresco, Claudio, Calabrò, Paolo, Leonardi, Sergio, Marcucci, Rossella, Rubboli, Andrea
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The clinical benefit of LDL cholesterol (LDL-C) lowering for cardiovascular disease prevention is well documented. This paper from the Italian Study Group on Atherosclerosis, Thrombosis and Vascular Biology summarizes current recommendations for treatment of hypercholesterolemia, barriers to lipid-lowering therapy implementation and tips to overcome them, as well as available evidence on the efficacy and safety of bempedoic acid. We also report an updated therapeutic algorithm for pharmacological LDL-C lowering in view of the introduction of bempedoic acid in clinical practice. [Display omitted]
ISSN:1537-1891
1879-3649
DOI:10.1016/j.vph.2022.107137